Maria Ryaboshapkina

7PUBLICATIONS
27CO-AUTHORS
PharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyComputational statistics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 15, 2026
Laroprovstat, the First Oral Small-Molecule PCSK9 Inhibitor for the Treatment of Hypercholesterolemia: Results From a Randomized, Single-Blind, Placebo-Controlled Phase 1 Trial in Treatment-Naïve Patients.

|Apr 22, 2024
IAPP Marks Mono-hormonal Stem-cell Derived β Cells that Maintain Stable Insulin Production in vitro and in vivo.

Jeffrey C Davis, Maria Ryaboshapkina, Jennifer H Kenty

|Apr 02, 2024
Dual glucagon-like peptide-1 and glucagon receptor agonism reduces energy intake in type 2 diabetes with obesity.

Rajna Golubic, Jane Kennet, Victoria Parker

|Nov 02, 2023
Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes.

Maria Ryaboshapkina, Regina Ye, Yumei Ye

|Jun 02, 2023
Sample size calculation for a NanoString GeoMx spatial transcriptomics experiment to study predictors of fibrosis progression in non-alcoholic fatty liver disease.

Maria Ryaboshapkina, Vian Azzu

|Sep 16, 2021
Modelling human liver fibrosis in the context of non-alcoholic steatohepatitis using a microphysiological system.

Tomasz Kostrzewski, Sophie Snow, Anya Lindström Battle

Pageof 2

Frequent Collaborators

1 joint publications

Tomasz Kostrzewski

1 joint publications

Anya Lindström Battle

1 joint publications

Manasa Surakala

1 joint publications

Julia Lindgren